|
PropoFlo
Pharmacological properties
Pharmacotherapeutic group: General anaesthetic
ATCvet code: QN01 AX 10
The product is a short-acting anaesthetic characterised by rapid onset and short duration of anaesthesia and by rapid recovery. The product produces unconsciousness by its depressant action on the central nervous system.
Intravenous injection is followed by extensive metabolism of propofol in the liver to inactive conjugates which are excreted in the urine (major route) and faeces. Elimination from the central compartment occurs rapidly, with an initial half-life of less than 10 minutes. After this initial phase, the decrease in plasma concentration is slower.
|
















